Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-04-05

FDA Approved: OVIDREL — Supplemental Application (EMD Serono, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for OVIDREL (chorionic gonadotropin alfa) submitted by EMD Serono, Inc., marking an update to its approved use/label…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ovidrel (Choriogonadotropin alfa)

Snippet

SUPPL AP for OVIDREL (CHORIOGONADOTROPIN ALFA)